Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272194 · ClinicalTrials.gov registry record · Phase 4
Ambu® Laryngeal Mask as an Intubation Conduit
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
NCT00272194 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 160 participants.
The verdict
NCT00272194, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the Ambu Laryngeal Mask can be used as an intubation conduit for endotracheal intubation.
Interventions
- DEVICE Laryngeal Mask Airway
- DEVICE Ambu Laryngeal Mask
- DEVICE Aintree Exchange Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00272194
The ClinicalTrials.gov registry entry for NCT00272194 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laryngeal Mask Airway is the first listed.
NCT00272194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00272194 about?
NCT00272194 is a clinical study titled "Ambu® Laryngeal Mask as an Intubation Conduit". The purpose of this study is to determine if the Ambu Laryngeal Mask can be used as an intubation conduit for endotracheal intubation.
What is the current status of trial NCT00272194?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2005-12. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00272194?
The interventions under investigation include: Laryngeal Mask Airway (DEVICE), Ambu Laryngeal Mask (DEVICE), Aintree Exchange Catheter (DEVICE).
Who is sponsoring clinical trial NCT00272194?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.